Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity
Wednesday, December 21, 2022Sosei Group Corporation the world leader in G proteincoupled receptor GPCR focused structurebased drug design SBDD and development has been notified by Pfizer that the first subject in a Phase clinical trial has been dosed with Pfizers candidate PF...
Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab
Wednesday, December 21, 2022Jazz Pharmaceuticals plc and Zymeworks Inc announced that Jazz has exercised its option to continue with its exclusive development and commercialization rights to Zymeworks zanidatamab in key markets including the US Europe and Japan pursuant to the...
EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan
Wednesday, December 21, 2022Novan Inc today announced that EPI Health LLC a fully consolidated subsidiary of Novan has entered into an exclusive license agreement with Sato Pharmaceutical Co Ltd Sato granting Sato the right to develop manufacture and market RHOFADE oxymetazolin...
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi
Tuesday, December 20, 2022Building on the ongoing efforts of the Department of Health Abu Dhabi DoH in spearheading Abu Dhabis healthcare ecosystem AstraZeneca a scienceled biopharmaceutical and one of the top biopharma companies globally and G Healthcare an AIpowered healt...
Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination
Monday, December 19, 2022Carrick Therapeutics an oncologyfocused biopharmaceutical company discovering and developing highly differentiated therapies and the Menarini Group Menarini a privatelyheld leading international pharmaceutical company today announced a clinical trial...
MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
Monday, December 19, 2022MediWound Ltd a fullyintegrated biopharmaceutical company focused on nextgeneration biotherapeutic solutions for tissue repair and regeneration today announced positive data from its Phase III study to evaluate the safety and efficacy of MW in the tr...
Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
Thursday, December 15, 2022Iterum Therapeutics plc a clinicalstage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multidrug resistant pathogens in both community and hospital settings today announced that the...
CASI Pharmaceuticals' Partner Juventas Announces New Drug Application For CNCT19 Accepted By China National Medical Products Administration
Thursday, December 15, 2022CASI Pharmaceuticals Inc a US biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products today announces that China National Medical Products Administration NMPA has accepted the new drug a...
Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent Menin Inhibitor BMF-219 in Type 2 Diabetes
Wednesday, December 14, 2022Biomea Fusion Inc a clinicalstage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients
FDA Grants Emergency Use Authorization for Thermo Fisher Scientific’s Monkeypox Test
Wednesday, December 14, 2022Thermo Fisher Scientific the world leader in serving science today announced the US Food and Drug Administration FDA has granted Emergency Use Authorization EUA for its Applied Biosystems TaqPath MonkeypoxOrthopox Virus DNA Kit a polymerase chain rea...
